FTRE · Fortrea Holdings Inc.
Market Cap
$1.68B
Shares
95.10M
FTRE metrics
70 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$17.70
Market cap
$1.68B
Price action
19 metricsPrice change (1W)
-5.9%
Price change (30D)
-4.0%
Price change (3M)
+10.1%
Price change (6M)
+84.2%
Price change (YTD)
+2.6%
Price change (1Y)
+68.4%
Trailing year
Price change (5Y)
—
52-week high
$20.70
52-week low
$8.40
Change from 52-week high
-14.5%
Change from 52-week low
+110.7%
Annualized volatility
74.7%
Beta
2.1
RSI (14D)
45.3
Price vs SMA 50
-3.2%
Price vs SMA 200
+21.1%
Avg volume (3M)
1.39M
Relative volume
0.6
Average dollar volume
$25.06M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
95.10M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.0×
reciprocal yield 104.2%
EV / EBITDA
38.1×
reciprocal yield 2.6%
EV / EBIT
—
P / sales
0.6×
reciprocal yield 159.0%
P / book
3.2
reciprocal yield 31.1%
FCF yield
11.6%
TTM · current market cap
Buyback yield
—
P / FCF
8.6
reciprocal yield 11.6%
P / operating cash flow
7.4
reciprocal yield 13.5%
Earnings yield
-5.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.9×
reciprocal yield 105.8%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 105.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-29
Profitability
9 metricsGross margin
—
Operating margin
-0.4%
Trailing 12 months
Net margin
-3.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$10.80M
Net income (TTM)
−$85.20M
Trailing 12 months
Diluted EPS (TTM)
$-0.81
FCF margin
7.3%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-4.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.68B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.6%
Year over year · more shares
Revenue CAGR (3Y)
-1.4%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+46.1%
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-16.3%
Return on assets
-3.1%
Debt / equity
2.0
Current ratio
1.0
EBITDA (TTM)
$67.50M
Free cash flow (TTM)
$196.00M
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
13.1
Return on invested capital
—
Trailing 12 months
Net cash
−$885.70M
Latest balance sheet
Cash & equivalents
$168.60M
Total assets
$2.71B
Total debt
$1.05B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$227.80M
Capital expenditures (TTM)
$31.80M
R&D (TTM)
—
SG&A (TTM)
$412.40M
Stock compensation (TTM)
$61.10M
R&D / revenue
—
Stock compensation / revenue
2.3%
Ownership (13F)
3 metrics13F filers
336
13F filer change QoQ
+1
Institutional ownership
105.5%
Short interest
3 metricsShort interest
12.1%
Latest settlement · 6.9 days to cover
Days to cover
6.9d
Short-squeeze score
72 / 100
Insider activity
2 metricsNet insider buying (90D)
−$4.28M
Insider-sentiment score
15 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1965040
CUSIP
34965K107
13F (30d)
215 filings
211 filers
Visit website
Investor relations